THYROSAFE Potassium Iodide Tablets, 65 mg, 40-Count Pack for Emergency Preparedness

THYROSAFE is a potassium iodide tablet designed to help protect the thyroid from radioactive iodine exposure, with 65 mg per tablet and 40 tablets per pack.

• 65 mg potassium iodide per tablet, 40 tablets per pack — keeps a supply on hand for an emergency.
• Helps prevent radioactive iodine from entering the thyroid — provides thyroid-specific protection during a radiation exposure incident.
• Scored tablets — make splitting easier when dosing instructions call for it.
• Suitable for all ages — supports household emergency preparedness.
• Current expiration date: June 2032 — gives this pack a stated date for preparedness planning.

Radioactive iodine can enter the thyroid during a radiation exposure incident, and exposure has been linked to thyroid cancer and other radiation-related illnesses. THYROSAFE is intended for emergency preparedness, including storage in a survival kit, home medical supplies, or a disaster response cache. Use is limited to emergencies and should follow direction from a public official.

What does THYROSAFE protect against?

THYROSAFE potassium iodide tablets help prevent radioactive iodine from getting into the thyroid during a radiation exposure incident. Potassium iodide is intended to address radioactive iodine uptake by the thyroid; it is not described as protection from every type of radiation exposure. Radioactive iodine exposure has been associated with thyroid cancer and other radiation-related illnesses.

• Thyroid-focused protection against radioactive iodine uptake.
• Approved for use in the event of radiation exposure.

When should THYROSAFE be taken?

Take THYROSAFE only when a public official directs its use during an emergency. If use is recommended, take it promptly in line with the official recommendation for potassium iodide tablets during that radiation incident. Dosing instructions are printed on the packaging, and the scored tablets can be split to make administration easier when needed.

• Follow public-official directions for whether and when to take it.
• Use the package dosing instructions; no dose should be inferred from the tablet strength alone.

What comes in the pack, and who is it for?

Each pack contains 40 THYROSAFE tablets, with 65 mg of potassium iodide in each tablet. The product is suitable for individuals of all ages, with dosing guided by the instructions on the packaging and any applicable public-official direction. The current expiration date is June 2032, and the tablets are described as having a long shelf life of years.

• Scoring helps make tablets easier to split for dosing.
• Intended storage settings include emergency kits, home medical supplies, and disaster response caches.

Possible side effects include salivary gland swelling, nausea, vomiting, diarrhea, stomachache, fever, headache, a metallic taste, and allergic reactions. THYROSAFE is best suited to people preparing an emergency supply for potential radioactive iodine exposure, rather than routine or self-directed use. Its purpose, pack of 40 scored tablets, and official-direction-only use make it a clearly defined addition to emergency preparedness supplies.